Other Assets - Additional Information (Detail) - ViaCyte, Inc. [Member] - USD ($) $ in Millions	9 Months Ended	12 Months Ended
Jun. 30, 2020	Sep. 30, 2019
Schedule of Investments [Line Items]
Original cost of investment	$ 5.3
Other-than-temporary impairment loss on investment	0.5	$ 4.8
Carrying amount of investment	$ 0.0	$ 0.5
Maximum [Member]
Schedule of Investments [Line Items]
Company's ownership percentage	1.00%

This item represents an other than temporary decline in value that has been recognized against an investment accounted for under the cost method of accounting. The excess of the carrying amount over the fair value of the investment represents the amount of the write down which is or was reflected in earnings. The written down value is a new cost basis with the adjusted value of the investment becoming its new carrying value. Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or inability of the investee to sustain an earnings capacity which would justify the carrying amount of the investment.

No definition available.

Name:	us-gaap_CostmethodInvestmentsOtherThanTemporaryImpairment
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration